GHK-Cu (Copper Peptide)

Copper-binding tripeptide

This page is educational only and is not medical advice. It is not an endorsement to use this compound. See the Educational Disclaimer for details.

Quick Answer

A naturally occurring small peptide that binds copper; its levels in human plasma decline with age. Best known as an ingredient in topical cosmetic skincare products, distinct from most other compounds in this database which are discussed mainly as injectables.

Why People Are Interested

Sits in an unusual middle ground: genuinely studied for skin-related effects at a cosmetic-science level (a real, if narrower, evidence base than most compounds here), while also picking up broader interest as a "longevity peptide" that outpaces what the cosmetic research actually supports.

What People Hope It May Do

Visible skin/appearance benefits — its most-studied use — plus more speculative interest in wound healing and hair-related effects. (Commonly discussed or proposed — not an established, evidence-backed outcome unless separately stated in Human Evidence above.)

Potential / Research Areas

Topical skin appearance/anti-aging outcomes

Wound healing (mostly preclinical/animal and some small human studies)

Hair-related research (early-stage)

How It May Work

Proposed roles include supporting collagen/elastin production pathways and antioxidant activity in skin — an area with a comparatively larger cosmetic-science research base than most peptides here, though still not equivalent to drug-level clinical evidence.

What Human Research Shows

More human data exists here than for most compounds in this database, largely from cosmetic-industry-sponsored studies on topical skin appearance measures — this is a different (and generally lower bar) evidence category than FDA drug-approval trials, and should be described as such.

What Preclinical Research Shows

Wound-healing research in animal models has been a common preclinical research area.

Element Evidence Snapshot™

Six independent readings, not one score. This reflects the volume and stage of research and discussion — it is not a rating of safety or effectiveness.

Human ResearchModerate
Preclinical ResearchModerate
Clinical Trial ActivityNone Identified
Real-World InterestModerate
Regulatory StatusCosmetic Ingredient
Research MomentumEstablished

"Real-World Interest" and "Research Momentum" reflect the volume of public discussion and research activity Element Health Labs has observed — an editorial judgment, not a measured statistic, and not a claim about clinical significance. Anecdotal popularity is not evidence of effectiveness.

What People Report

Real-World / Anecdotal Experience — in development. Element Health Labs hasn't yet compiled a reliable synthesis of public anecdotal reports for GHK-Cu (Copper Peptide). When this section is live, it will summarize commonly reported themes from public discussion, clearly separated from the scientific evidence above. Anecdotal reports are not clinical evidence, and individual experiences vary. See Real Experiences for how this is being built.

What Experts Are Saying

Curated commentary specific to GHK-Cu (Copper Peptide) is planned as the Expert & Creator Library grows. Being listed there does not imply an expert's endorsement of Element Health Labs.

Clinical Trials

For the current, authoritative list of registered trials involving GHK-Cu (Copper Peptide), search ClinicalTrials.gov directly — trial status changes frequently, and that registry is the source of truth, not a static summary on this page.

Potential Risks & Side Effects

Widely used topically in commercial skincare at low concentrations. General topical-cosmetic safety information only — no injectable-use safety claims should be made, and any non-topical use is a different risk category entirely and outside this business's scope.

Regulatory Status

Regulated as a cosmetic ingredient, not as an FDA-approved drug. Cosmetics in the US are not "FDA-approved" the same way drugs are — the FDA does not pre-approve most cosmetic ingredients before marketing. This distinction should always be made explicit: "used in FDA-regulated cosmetic products" is accurate; "FDA-approved" is not.

What We Still Don't Know

How its cosmetic-level evidence would or wouldn't translate to any of the broader claims sometimes attached to it, and how effects vary by formulation and delivery method.

Limitations of Evidence

Many topical studies are cosmetic-industry funded and use surrogate measures (skin appearance scores) rather than hard clinical endpoints.

Key Takeaway. GHK-Cu (Copper Peptide) is a real area of scientific and public interest — but interest, mechanism plausibility, and proof are three different things. As of this review: human research is moderate, preclinical research is moderate, and its regulatory status is Cosmetic Ingredient. Read the sections above — not just this summary — before forming a view, and talk to a licensed healthcare provider before making any health decision.

Keep Researching

Sources. Key studies and full references for this entry are still being compiled and verified — see data/peptides/ghk-cu.md in the project repo for the current compliance-review status. This page will not publish claims backed by unverified or fabricated citations.
Last reviewed: 2026-09-10 — Key Studies citation gap closed; the specific 71-women/41-women trial claims confirmed directly against the already-cited PMC6073405 review, which quotes both studies nearly verbatim.